This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Baillargeon, J. Articles by Linthicum, L. Search for Related Content PubMed Articles by Baillargeon, J. Articles by Linthicum, L. Social Bookmarking                         What's this?

Management of Tuberculosis in the Texas Prison System

Department of Pediatrics, University of Texas Health Science Center, 7703 Floyd Curl Drive, San Antonio, TX 78284-7802. Phone: (210) 567-5247. baillargeon{at}uthscsa.edu

Michael Kelley, MD, MPH

Department of Preventive Medicine and Community Health, University of Texas Medical Branch in Galveston, Texas; Office of Preventive Medicine, Texas Department of Criminal Justice in Huntsville, Texas

Michael J. Lichtenstein, MD, MSc

Department of Medicine, University of Texas Health Science Center in San Antonio, Texas; Frederic C. Bartter General Clinical Research Center

Hal B. Jenson, MD

The Department of Pediatrics, University of Texas Health Science Center in San Antonio, Texas

Lannette Linthicum, MD

Health Services Department, Texas Department of Criminal Justice in Huntsville, Texas

Prison inmates are at increased risk of tuberculosis (TB) compared to the general population. A number of TB outbreaks have been reported in correctional settings, some of which have spread to the general community. The purpose of the present study was to describe the incidence of TB and the patterns of treatment in the Texas prison system. The incidence of TB in the Texas Department of Criminal Justice (TDCJ) prison population during a 12-month period was 27 cases per 100,000 inmates. In general, this rate persisted across each of the sociodemographic groups under study, but was 15-fold greater among HIV-infected inmates (395 cases per 100,000). Overall, 59% of the sample were prescribed antitubercular therapy for at least the defined standard duration; 45% were prescribed anti-TB therapy for longer than the standard duration; ethambutol was included in the initial therapy among 95% of inmates treated with anti-TB therapy; and approximately 33% were prescribed pyrazinamide for a period of less than 56 days. Approximately 36% of the study sample began antitubercular pharmacotherapy prior to incarceration, while 7% were released from prison prior to completion of their therapy. In view of previously reported prison-to-general-community TB transmission, understanding TB prevalence and treatment patterns in correctional settings holds clinical and public health relevance beyond the prison setting.

Journal of Correctional Health Care, Vol. 9, No. 1, 77-93 (2002)
DOI: 10.1177/107834580200900108


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?